E-SCREEN

E-Screen is a bioassay method used to assess the estrogenic activity of chemicals and extracts from environmental samples. This assay is based on the proliferation of estrogen-sensitive cells in response to substances that mimic or block the action of the natural hormone estrogen. The E-Screen assay is a critical tool in environmental health research, helping scientists understand the potential impact of environmental estrogens, also known as xenoestrogens, on human health and wildlife.

Overview

The E-Screen assay was developed in the early 1990s by Dr. Ana Soto and colleagues. It utilizes a line of human breast cancer cells, known as MCF-7 cells, which proliferate in the presence of estrogenic substances. The principle behind the E-Screen is that substances with estrogenic activity will bind to estrogen receptors in the cells, leading to cell division and growth. The extent of cell proliferation is measured and compared to the proliferation caused by known concentrations of estradiol, the natural estrogen, providing a quantitative measure of the sample's estrogenic activity.

Methodology

The E-Screen assay involves several key steps: 1. Preparation of Test Samples: Samples, which can be chemical compounds or extracts from environmental matrices (e.g., water, soil), are prepared for testing. 2. Cell Culture: MCF-7 cells are cultured in appropriate conditions to ensure their viability and responsiveness to estrogen. 3. Exposure: The cells are exposed to various concentrations of the test samples or estradiol (as a positive control) for a specific period, usually 72 hours. 4. Assessment of Cell Proliferation: After exposure, cell proliferation is assessed using methods such as the sulforhodamine B (SRB) assay or DNA quantitation. The level of proliferation is indicative of the estrogenic activity of the test substance.

Applications

The E-Screen assay has been widely used in environmental and health sciences for:

• Detecting the presence of estrogenic compounds in environmental samples, such as water bodies affected by industrial discharges or agricultural runoff.
• Screening chemicals used in consumer products, pharmaceuticals, and industrial processes for estrogenic activity as part of safety assessments.
• Investigating the mechanisms of action of known or suspected endocrine disruptors.

Advantages and Limitations

Advantages:

• The E-Screen provides a sensitive and relatively straightforward method for assessing estrogenic activity.
• It can be used to test a wide range of substances and environmental extracts.
• The assay contributes to our understanding of the potential health risks posed by exposure to environmental estrogens.

Limitations:

• The E-Screen is specific to substances that exert their effects through estrogen receptors and may not detect other mechanisms of endocrine disruption.
• Interpretation of results can be complex, especially when assessing mixtures of compounds.
• The assay requires careful handling and culture of human cell lines, necessitating specialized laboratory facilities and expertise.

Conclusion

The E-Screen assay remains a valuable tool in the field of environmental health research, offering insights into the estrogenic activity of substances and their potential impact on human health and the environment. As concerns over endocrine disruptors continue to grow, methods like the E-Screen play a crucial role in identifying and mitigating these risks.

   This article is a medical stub. You can help WikiMD by expanding it!

• 

  17β-estradiol

• 

  MCF-7 Cells

• 

  Tissue Culture Hood

• 

  PBB Protein ESR1

• 

  Estrogen Receptor Beta

• 

  Estrogenic Endocrine Disruptors

• 

  Protein TGFB3